The availability of advanced hematology care varies significantly by geography, with North America currently holding over 50% of the global share. However, the Immune Thrombocytopenia Market region of Asia-Pacific is identified as the fastest-growing sector. Increased healthcare spending in China and India is facilitating better access to high-cost biologics, which were previously unavailable to the majority of the population in these areas.

FAQ

• Which country has the highest prevalence of ITP? The United States reports a high number of cases, with roughly 6.1 per 100,000 individuals diagnosed annually.

• Is ITP more common in men or women? In adults, ITP is more frequently diagnosed in women, often associated with other autoimmune conditions.